Results 11 to 20 of about 83,758 (359)

Monitoring Low Molecular Weight Heparins at Therapeutic Levels: Dose-Responses of, and Correlations and Differences between aPTT, Anti-Factor Xa and Thrombin Generation Assays

open access: goldPLoS ONE, 2015
Background Low molecular weight heparins (LMWH’s) are used to prevent and treat thrombosis. Tests for monitoring LMWH’s include anti-factor Xa (anti-FXa), activated partial thromboplastin time (aPTT) and thrombin generation.
Owain D Thomas   +4 more
semanticscholar   +3 more sources

Pengaruh Profilaksis Trombosis Vena Dalam dengan Heparin Subkutan dan Intravena terhadap aPTT dan Jumlah Trombosit pada Pasien Kritis di ICU RSUP Dr. Kariadi Semarang

open access: diamondJAI (Jurnal Anestesiologi Indonesia), 2012
Latar belakang: Heparin telah digunakan sebagai terapi maupun sebagai profilaksis primer TVD, walaupun keamanan heparin khususnya pada pasien kritis yang memiliki risiko tinggi perdarahan masih merupakan subyek perdebatan.
Satrio Adi Wicaksono   +2 more
doaj   +3 more sources

Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement

open access: yesJournal of Clinical Medicine, 2022
Continuous intravenous unfractionated heparin (UFH) is administered routinely in the intensive care unit (ICU) for the anticoagulation of patients, and monitoring is performed by the activated partial thromboplastin time (APTT) or anti-Xa activity ...
B. Lardinois   +9 more
semanticscholar   +1 more source

APTT therapeutic range for monitoring unfractionated heparin therapy. Significant impact of the anti‐Xa reagent used for correlation

open access: yesJournal of Thrombosis and Haemostasis, 2021
Unfractionated heparin (UFH) therapy is monitored by using the anti‐activated factor X (anti‐Xa) activity, or the activated partial thromboplastin time (APTT), which remains the most widely used assay.
P. Toulon, M. Smahi, Neila De Pooter
semanticscholar   +1 more source

Monitoring Unfractionated Heparin in Adult Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): ACT, APTT, or ANTI-XA?

open access: yesCritical Care Research and Practice, 2021
Background During ECMO, anticoagulants, in particular, unfractionated heparin (UFH), are commonly used and monitored by laboratory tests, including ACT, APTT, and anti-Xa level.
T. Nguyen   +10 more
semanticscholar   +1 more source

ACTION OF VENOM OF VIPERA SNAKE OF UKRAINE ON BLOOD COAGULATION in vitro [PDF]

open access: yesBiotechnologia Acta, 2022
Aim. In this study we focused on the search of fibrinogen-targeted proteases in the venom of Vipera renardi, Vipera nikolskii and Vipera berus. Venom of Vipera berus was also fractionated on Q-sepharose and action of separated fractions on human blood ...
E. Iskandarov   +7 more
doaj   +1 more source

Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys

open access: yesBlood, 2012
Husam S. Younis   +6 more
exaly   +2 more sources

The value of coagulation parameters as prognostic indicators in snake envenomation [PDF]

open access: yesMedical Laboratory Journal, 2023
Gauri Metkar , Shalaka Saraf Background: Snakebite is a potentially life-threatening emergency that can be treated effectively. Snake envenomation can cause hematologic and coagulation abnormalities. In this respect, tests such as prothrombin time (PT),
Gauri Metkar, Shalaka Saraf
doaj  

DIFFERENCES VALUE OF PT AND APTT IN EXAMINATION OF ELECTROMECHANICAL AND PHOTO-OPTICAL METHOD

open access: yesJournal of Vocational Health Studies, 2021
Background: Examination of PT and APTT in hospitals and clinical laboratories by utilizing the use of different instruments and methods. Examination of PT and APTT can be implemented through electromechanical or photo-optical techniques to detect changes
Beytri Ramadhani
doaj   +1 more source

Elevated PT and aPTT [PDF]

open access: yesClinical Chemistry, 2018
A 52-year-old man with no significant past medical history presented with epistaxis for 1 week. He had no history of bleeding disorders and was not on anticoagulation medication. Family history of bleeding disorders was unknown. Table 1 provides a summary of relevant laboratory studies. View this table: Table 1. Laboratory studies performed.
Ian M, Harrold, Olajumoke, Oladipo
openaire   +2 more sources

Home - About - Disclaimer - Privacy